Bristol-Myers Squibb

Gilead Vs. Challengers In The Hepatitis C Race
Seeking Alpha
Thu, 11/7/13 - 09:52 am
Gilead
hepatitis C
AbbVie
Bristol-Myers Squibb
JNJ
Merck
simeprevir
sofosbuvir
daclatasvir
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wed, 11/6/13 - 10:39 am
GSK
Bayer
Sanofi
Novartis
JNJ
Bristol-Myers Squibb
Merck
AbbVie
Eli Lilly
Pfizer
AstraZeneca
Bristol-Myers Squibb First to Japan in New Hepatitis C Therapy Race
Motley Fool
Wed, 11/6/13 - 10:27 am
Japan
Bristol-Myers Squibb
hepatitis C
asunaprevir
We Like What We're Seeing In Big Pharma
Seeking Alpha
Tue, 11/5/13 - 08:42 am
Bristol-Myers Squibb
AbbVie
Eli Lilly
Merck: Why Oncology Smells Like Money
Seeking Alpha
Mon, 11/4/13 - 09:49 am
Merck
oncology
Roche
Bristol-Myers Squibb
MK-3475
melanoma
Bristol-Myers Vs. Abbvie In Potential Humira Rivalry
Seeking Alpha
Mon, 11/4/13 - 09:47 am
AbbVie
Humira
Bristol-Myers Squibb
clazakizumab
Bristol seeks Japan approval of all-oral hepatitis C treatment
Yahoo/Reuters
Sat, 11/2/13 - 11:56 am
Bristol-Myers Squibb
daclatasvir
asunaprevir
hepatitis C
hepatitis
BMS rheumatoid arthritis drug clazakizumab causes a stir at ACR
Pharma Times, UK
Tue, 10/29/13 - 12:14 pm
rheumatoid arthritis
clazakizumab
Bristol-Myers Squibb
Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade
Barron's
Mon, 10/28/13 - 12:10 pm
Bristol-Myers Squibb
nivolumab
lung cancer
Q3 Earnings Roundup for Pharmaceutical Stocks
InvestorPlace
Fri, 10/25/13 - 11:37 am
earnings
Amgen
Eli Lilly
Bristol-Myers Squibb
[video]2 Big Pharma Giants Headed in Opposite Directions
Motley Fool
Fri, 10/25/13 - 10:18 am
GSK
Bristol-Myers Squibb
Bristol-Myers Squibb - There Is Life After Plavix
Seeking Alpha
Thu, 10/24/13 - 10:19 am
Plavix
Bristol-Myers Squibb
JNJ
PFE
Ex-Bristol-Myers executive gets 1 yr in prison for insider trading
Yahoo/Reuters
Wed, 10/23/13 - 06:32 pm
insider trading
Bristol-Myers Squibb
Bristol-Myers’s Profit Tops Estimates on Sales Growth
Bloomberg
Wed, 10/23/13 - 08:40 am
Bristol-Myers Squibb
earnings
Anticipated Earnings Increase for Bristol-Myers Squibb
Forbes
Mon, 10/21/13 - 11:52 am
Bristol-Myers Squibb
earnings
Bristol-Myers Researcher Falsified Data In Grants And PhD Thesis
Pharmalot
Mon, 10/21/13 - 09:55 am
Bristol-Myers Squibb
R&D
EP Vantage: Eliquis projected sales off 60% for 2014
Fierce Pharma
Fri, 10/18/13 - 11:04 am
Eliquis
bloodthinners
Pfizer
Bristol-Myers Squibb
Cancer immunotherapies set to storm onto the market, analysts say
Fierce Biotech
Wed, 10/16/13 - 10:03 am
cancer immunotherapy
Merck
Roche
Bristol-Myers Squibb
Novogen Is Poised To Soar As A Major Partnership Announcement Is Imminent
Seeking Alpha
Tue, 10/15/13 - 08:39 am
Novogen
Bristol-Myers Squibb
Merck
cancer
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals

Pages